Global Immunology Drugs Market

Report ID : 1328 | Published : 2022-07-15 | Pages: | Format:

The market size of the Global Immunology Drugs Market in the year 2021 is valued at 88.85 billion and is predicted to reach 183.49 billion by the year 2030 at an 8.7% CAGR during the projected period.

The medical and biological research field known as Immunology Drugs focuses on the immune system. Autoimmune disorders develop when the immune system assaults the body that it is supposed to defend. People with autoimmune disorders have a deficiency in their immune system that prevents them from telling "self" molecules apart from "non-self" or "foreign" molecules. Numerous laboratory tests are available in Immunology Drugs to identify autoimmune disorders. The increased frequency of immunological illnesses brought on by environmental changes and changing lifestyles, as well as the increased awareness of immunological disease in both developed and developing nations, are the driving forces behind the market's expansion. Some of the major market participants are continually emphasizing innovation and expanding their product lines to improve patient treatment outcomes. It is anticipated that this will expand even further during the projection period. There is a growing patient population with autoimmune illnesses as a result of many environmental variables such as stress, infection, exposure to hazardous chemicals, and nutritional components.

The worldwide Immunology Drugs industry is likely to experience growth restraints over the forecast period due to a lack of technological advancements and expensive treatment costs. Additionally, many negative effects are associated with these treatments, such as fever, irregular or pounding heartbeat, muscle aches, allergic reactions, infections, etc. Therefore, the aforementioned limitations and the stringent reimbursement practices in emerging countries hinder market expansion throughout the projection period.

Market Segmentation:

The Immunology Drugs Market is segmented on the basis of Drug Class, Distribution Channel, and Disease Indications. Based on Drug Class, the market is segmented into Monoclonal antibodies, Fusion Proteins, Immunosuppressants, Polyclonal antibodies, and Other Drug classes. Based on Distribution Channel, the market is segmented as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution channels. Based on Disease Indications, the market is segmented as Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, and Other disease Indication.

Based on Drug Class, the immunosuppressants segment is accounted as a significant contributor to the Immunology Drugs Market.

During the projection period, the immunosuppressants segment is anticipated to expand at a faster rate. Leading market participants' intense focus on R&D to establish the rising number of regulatory approvals for these pharmaceuticals is credited with this segment's quick expansion. Additionally, immunosuppressants are becoming more widely used in developing countries because of their superior therapeutic efficacy, which contributes to their rapid growth rate. The main driver of immunosuppressants is the rise in autoimmune diseases such as multiple sclerosis, alopecia areata, and arthritis. An increase in organ transplant procedures like kidney and liver transplants due to the rise in cases of organ failure fuels the development of immunosuppressants.

Based on Disease Indications, the inflammatory bowel disease segment is accounted as a major contributor to the Immunology Drugs Market.

In the forecast period, the market will be dominated by the segment for inflammatory bowel disease. Over the forecast period, market growth is anticipated to be fuelled by the increasing prevalence of Crohn's disease and ulcerative illness worldwide. The escalating rates of Crohn's disease and ulcerative colitis are caused by a number of factors, including immune system instability, environmental triggers, and genetic predisposition. Most people with Crohn's disease or ulcerative colitis have a family history of the condition. The market for treating inflammatory bowel illness is anticipated to develop as a result of this. Additionally, it is predicted that the market will rise in the next years due to the rising use of biologics for therapy and the availability of potent pipeline medications like upadacitinib, risankizumab, tofacitinib, ustekinumab, and others.

The North America Immunology Drugs Market holds a significant revenue share in the region.

Due to the availability of superior reimbursement laws, the huge potential to invest substantial funds in creating Immunology Drugs treatments, and the advancement of technology, North America dominates the worldwide market for Immunology Drugs pharmaceuticals. The larger patient pool in the regions, rising economies, increased government activities and increased awareness all point to the growing demand for Immunology Drugs drugs. The United States now dominates the global market due to its well-developed healthcare infrastructure, higher prevalence of chronic illnesses, and higher rates of diagnosis and treatment among patient populations.

Competitive Landscape

The key players in the Immunology Drugs Market have shifted their focus toward bio-based components for product manufacturing and are initiating significant strategies such as mergers, acquisitions, and through partnerships with regional and international companies to expand their product offerings and expand their global market presence. Some of the major key players in the Immunology Drugs Market are Eli Lilly, AbbVie Inc, F.Hoffmann-La roche Ltd, Amgen Inc, Pfizer, Novartis, Astellas, Alector, ImmuNext, Merck sharp & Dohme Corp, and UCB S.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Immunology Drugs Market Snapshot

Chapter 4. Global Immunology Drugs Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Drug Class Estimates & Trend Analysis

5.1. By Drug Class & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Drug Class:

5.2.1. Monoclonal antibody

5.2.2. Fusion Proteins

5.2.3. Immunosuppressant

5.2.4. Polyclonal antibody

5.2.5. Other Drug Class

Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis

6.1. By Distribution Channel & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Distribution Channel:

6.2.1. Hospital Pharmacies

6.2.2. Retail Pharmacies

6.2.3. Online Pharmacies

6.2.4. Other Distribution Channel

Chapter 7. Market Segmentation 3: By Disease Indications Estimates & Trend Analysis

7.1. By Disease Indications & Market Share, 2020 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Disease Indications:

7.2.1. Rheumatoid Arthritis

7.2.2. Psoriatic Arthritis

7.2.3. Plaque Psoriasis

7.2.4. Ankylosing Spondylitis

7.2.5. Inflammatory Bowel disease

7.2.6. Other disease Indication

Chapter 8. Immunology Drugs Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts By Drug Class, 2020-2030

8.1.2. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2020-2030

8.1.3. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

8.1.4. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

8.2. Europe

8.2.1. Europe Immunology Drugs Market revenue (US$ Million) By Drug Class, 2020-2030

8.2.2. Europe Immunology Drugs Market revenue (US$ Million) By Distribution Channel, 2020-2030

8.2.3. Europe Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

8.2.4. Europe Immunology Drugs Market revenue (US$ Million) by country, 2020-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Immunology Drugs Market revenue (US$ Million) By Drug Class, 2020-2030

8.3.2. Asia Pacific Immunology Drugs Market revenue (US$ Million) By Distribution Channel, 2020-2030

8.3.3. Asia Pacific Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

8.3.4. Asia Pacific Immunology Drugs Market revenue (US$ Million) by country, 2020-2030

8.4. Latin America

8.4.1. Latin America Immunology Drugs Market revenue (US$ Million) By Drug Class, (US$ Million)

8.4.2. Latin America Immunology Drugs Market revenue (US$ Million) By Distribution Channel, (US$ Million)

8.4.3. Latin America Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

8.4.4. Latin America Immunology Drugs Market revenue (US$ Million) by country, 2020-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Immunology Drugs Market revenue (US$ Million) By Drug Class, (US$ Million)

8.5.2. Middle East & Africa Immunology Drugs Market revenue (US$ Million) By Distribution Channel, (US$ Million)

8.5.3. Middle East & Africa Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2020-2030

8.5.4. Middle East & Africa Immunology Drugs Market revenue (US$ Million) by country, 2020-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Eli Lilly and Company

9.2.2. AbbVie Inc

9.2.3. F.Hoffmann-La roche Ltd

9.2.4. Amgen Inc

9.2.5. Pfizer

9.2.6. Novartis

9.2.7. Astellas

9.2.8. Alector

9.2.9. ImmuNext

9.2.10. Merck sharp & Dohme Corp.

9.2.11. UCB SA

9.2.12. Other Prominent Players

Segmentation of Immunology Drugs Market-

By Drug Class:

  • Monoclonal antibody
  • Fusion Proteins
  • Immunosuppressant
  • Polyclonal antibody
  • Other Drug Class

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other Distribution Channel

By Disease Indications

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
  • Inflammatory Bowel disease
  • Other disease Indication

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients